Tangub, Rowena N.

HRN: 22-05-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFUROXIME 1.5GM (VIAL)
10/03/2022
10/03/2022
IVTT
1 Vial
On Call To OR
For TAHBSO
Waiting Final Action 
10/03/2022
CEFUROXIME 750MG (VIAL)
10/03/2022
10/10/2022
IV
750mg
Q 8 HRS
S/P TAHBSO
10/04/2022
CEFUROXIME 500MG (TAB)
10/04/2022
10/11/2022
PO
1Tab
Q12H
S/p EL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: